Note Agreements in the Pharmaceuticals Industry

1,725 Contracts & Agreements

Browse by Company

4Front Ventures Corp. (3 contracts)
60 DEGREES PHARMACEUTICALS, INC. (29)
Acacia Diversified Holdings, Inc. (1)
Acasti Pharma Inc. (8)
Accelerated Pharma, Inc. (8)
Acer Therapeutics Inc. (12)
ACHILLION PHARMACEUTICALS INC (7)
Acreage Holdings, Inc. (2)
ACURA PHARMACEUTICALS, INC (20)
Adamis Pharmaceuticals Corp (17)
ADIAL PHARMACEUTICALS, INC. (9)
Aegerion Pharmaceuticals, Inc. (8)
AEOLUS PHARMACEUTICALS, INC. (5)
AEON Biopharma, Inc. (8)
AERIE PHARMACEUTICALS INC (2)
Aerpio Pharmaceuticals, Inc. (4)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (3)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (6)
Alexza Pharmaceuticals Inc. (8)
ALIMERA SCIENCES INC (1)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (28)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (2)
AmeriCann, Inc. (5)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (6)
AMYLIN PHARMACEUTICALS INC (6)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (4)
ANI Pharma Inc (1)
Apimeds Pharmaceuticals US, Inc. (10)
Applied BioSciences Corp. (5)
APRICUS BIOSCIENCES, INC. (18)
Aquestive Therapeutics, Inc. (2)
ARADIGM CORP (6)
Aralez Pharmaceuticals Inc. (15)
ARIAD PHARMACEUTICALS INC (5)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (3)
Assertio Therapeutics, Inc (7)
Astex Pharmaceuticals, Inc (3)
AUXILIUM PHARMACEUTICALS INC (1)
AVALON PHARMACEUTICALS INC (3)
AVENUE THERAPEUTICS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (13)
AYTU BIOSCIENCE, INC (7)
Bakhu Holdings, Corp. (2)
Barrel Energy Inc. (2)
Baudax Bio, Inc. (1)
Bespoke Extracts, Inc. (4)
Big Rock Partners Acquisition Corp. (12)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (1)
BioPharmX Corp (6)
Blue Water Acquisition Corp. (2)
BODY & MIND INC. (4)
Bohai Pharmaceuticals Group, Inc. (6)
Boston Therapeutics, Inc. (13)
Bristol-Myers Squibb (13)
Canbiola, Inc. (31)
Cancer Prevention Pharmaceuticals, Inc. (7)
Cannabics Pharmaceuticals Inc. (6)
CANNAPHARMARX, INC. (2)
CANNAPOWDER, INC. (6)
Canopy Growth Corp (1)
CARDAX, INC. (6)
Celexus, Inc (4)
CELGENE CORP (20)
Cerecor Inc. (2)
Charlotte's Web Holdings, Inc. (2)
CHINA PHARMA HOLDINGS, INC. (3)
Cingulate Inc. (11)
Citius Pharmaceuticals, Inc. (7)
Clever Leaves Holdings Inc. (3)
CLS Holdings USA, Inc. (47)
Cocrystal Pharma, Inc. (9)
COLLEGIUM PHARMACEUTICAL, INC (2)
Columbia Care Inc. (3)
ContraVir Pharmaceuticals, Inc. (3)
Corcept Therapeutics Incorporated (1)
CorMedix Inc. (4)
COSMO VENTURES INC (23)
CUBIST PHARMACEUTICALS INC (2)
Cure Pharmaceutical Holding Corp. (13)
Dova Pharmaceuticals Inc. (1)
Egalet Corp (1)
ELITE PHARMACEUTICALS INC (3)
Eloxx Pharmaceuticals, Inc. (5)
Endexx Corp (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (2)
EPIX Pharmaceuticals, Inc. (3)
Eton Pharmaceuticals, Inc. (2)
Evofem Biosciences, Inc. (14)
Evolus, Inc. (3)
Exactus, Inc. (11)
EYENOVIA, INC. (1)
FERMAVIR PHARMACEUTICALS, INC. (2)
Furiex Pharmaceuticals, Inc. (1)
Gala Pharmaceutical Inc. (1)
GB SCIENCES INC (28)
GENAISSANCE PHARMACEUTICALS INC (1)
GREEN HYGIENICS HOLDINGS INC. (5)
Green Thumb Industries Inc. (2)
GridIron BioNutrients, Inc. (11)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (4)
Haymaker Acquisition Corp. III (1)
HERATSI PHARMACEUTICALS (2)
Horizon Pharma plc (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
IMAGING3 INC (19)
INNOVATE BIOPHARMACEUTICALS, INC. (10)
Innoviva, Inc. (2)
IntelGenx Technologies Corp. (6)
Intersect ENT, Inc. (1)
ISTA PHARMACEUTICALS INC (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (27)
Jazz Pharmaceuticals plc (3)
Jiangbo Pharmaceuticals, Inc. (1)
Johnson & Johnson (14)
Journey Medical Corp (1)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (1)
Kannalife Inc (5)
Kaya Holdings, Inc. (6)
Kedem Pharmaceuticals Inc. (4)
KEMPHARM, INC (6)
KID CASTLE EDUCATIONAL CORP (2)
Level Brands, Inc. (5)
Lilly (Eli) & Co. (19)
LIPELLA PHARMACEUTICALS INC (3)
Lotus Pharmaceuticals, Inc. (1)
Luckwel Pharmaceuticals Inc. (1)
Mallinckrodt (9)
Marijuana Co of America, Inc. (3)
MedGen, Inc. (6)
Medicine Man Technologies, Inc. (9)
MedMen Enterprises, Inc. (3)
Merck (49)
MICROCHANNEL TECHNOLOGIES CORP (25)
Milestone Pharmaceuticals Inc. (2)
MJ BIOTECH, INC. (3)
MJ Holdings, Inc. (10)
Mylan N.V. (3)
MYnd Analytics, Inc. (68)
NAREK PHARMACEUTICALS (2)
NEKTAR THERAPEUTICS (5)
Neos Therapeutics, Inc. (7)
Neuralstem, Inc. (1)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (10)
NEXIEN BIOPHARMA, INC. (9)
Notis Global, Inc. (23)
NovaBay Pharmaceuticals, Inc. (12)
Novan, Inc. (2)
NPS PHARMACEUTICALS INC (1)
OCULAR THERAPEUTIX, INC (2)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (1)
One World Pharma, Inc. (14)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OptiNose, Inc. (2)
ORAMED PHARMACEUTICALS INC. (3)
OSCIENT PHARMACEUTICALS CORP (2)
Osmotica Pharmaceuticals plc (3)
Pacira Pharmaceuticals, Inc. (1)
Panacea Acquisition Corp (3)
Paratek Pharmaceuticals, Inc. (1)
PaxMedica, Inc. (7)
PEAK PHARMACEUTICALS, INC. (21)
Perrigo (4)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (2)
Pfizer (3)
Pharmagreen Biotech Inc. (4)
Phathom Pharmaceuticals, Inc. (2)
Phoenix Life Sciences International Limited. (1)
Planet 13 Holdings Inc. (3)
PLAYERS NETWORK (37)
PONIARD PHARMACEUTICALS, INC. (2)
Prestige Brands Holdings Inc (1)
Processa Pharmaceuticals, Inc. (4)
ProPhase Labs, Inc. (7)
PROVECTUS BIOPHARMACEUTICALS, INC. (14)
QUANTA INC (4)
RADIENT PHARMACEUTICALS Corp (10)
Rani Therapeutics Holdings, Inc. (1)
Recro Pharma, Inc. (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (27)
Revance Therapeutics, Inc. (1)
Rib-X Pharmaceuticals, Inc. (11)
ROCK CREEK PHARMACEUTICALS, INC. (3)
SALIX PHARMACEUTICALS LTD (6)
SCYNEXIS INC (3)
Semnur Pharmaceuticals, Inc. (1)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
SIGA TECHNOLOGIES INC (4)
Sucampo Pharmaceuticals, Inc. (3)
Sunset Island Group (5)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (2)
Synovics Pharmaceuticals (2)
TAPESTRY PHARMACEUTICALS, INC (1)
Target Group Inc. (5)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (76)
Tenzing Acquisition Corp. (8)
Terra Tech Corp. (54)
TETRALOGIC PHARMACEUTICALS CORP (6)
TETRAPHASE PHARMACEUTICALS INC (1)
Textmunication Holdings, Inc. (31)
THAR PHARMACEUTICALS INC (2)
TherapeuticsMD, Inc. (28)
Theravance Biopharma, Inc. (2)
Thomas Pharmaceuticals, Ltd. (2)
Tilray, Inc. (12)
TILT Holdings Inc. (14)
TITAN PHARMACEUTICALS INC (3)
Tribute Pharmaceuticals Canada Inc. (7)
Trulieve Cannabis Corp. (2)
United Cannabis Corp (6)
Upjohn Inc (1)
Urigen Pharmaceuticals, Inc. (6)
Vallon Pharmaceuticals, Inc. (5)
VASO ACTIVE PHARMACEUTICALS INC (1)
Verano Holdings Corp. (3)
VERBENA PHARMACEUTICALS INC (2)
VIA Pharmaceuticals, Inc. (10)
VION PHARMACEUTICALS INC (1)
VioQuest Pharmaceuticals, Inc. (3)
Vireo Health International, Inc. (1)
Virpax Pharmaceuticals, Inc. (16)
Vitality Biopharma, Inc. (3)
VIVUS INC (3)
WEED, INC. (2)
XERIS PHARMACEUTICALS INC (1)
Zoetis (4)
ZOGENIX, INC. (1)
Zomedica Pharmaceuticals Corp. (2)

Recent Contracts

Form of Convertible Promissory Note (Kaya Holdings, Inc., Filed With SEC on December 3, 2024)
Form of Note (Biofrontera Inc., Filed With SEC on November 27, 2024)
Secured Demand Promissory Note dated August 23, 2024 issued to Pasquale Ferro (Canbiola, Inc., Filed With SEC on November 19, 2024)
Third Amendment to Secured Promissory Note, dated November 13, 2024 (Charlotte's Web Holdings, Inc., Filed With SEC on November 14, 2024)
Second Amended and Restated Convertible Promissory Note, dated as of April 2, 2024, issued by Denali Capital Acquisition Corp. to Denali Capital Global Investments LLC (Semnur Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Secured Promissory Note, dated as of November 5, 2024, between NovaBay Pharmaceuticals, Inc., as borrower, and PRN Physician Recommended Nutriceuticals, LLC, as lender (NovaBay Pharmaceuticals, Inc., Filed With SEC on November 6, 2024)
Promissory Note dated October 28, 2024 from Iterum Therapeutics International Limited to Pfizer Inc (Iterum Therapeutics plc, Filed With SEC on November 1, 2024)
Convertible Promissory Note dated October 3, 2024 issued to Quick Capital, LLC (NEXIEN BIOPHARMA, INC., Filed With SEC on October 22, 2024)
Note Purchase Agreement dated October 3, 2024 between the Company and Quick Capital, LLC (NEXIEN BIOPHARMA, INC., Filed With SEC on October 22, 2024)
Promissory note in the amount of $23,791,657 payable by Aphria Diamond Inc (Tilray, Inc., Filed With SEC on October 10, 2024)
Subsidiary Guarantee Amendment, dated October 8, 2024, made by certain of Scilex Holding Company subsidiaries in favor of the holders of that certain Tranche A Note (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
Tranche B Senior Secured Convertible Note, dated October 8, 2024, issued by Scilex Holding Company to the Company (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
Amended Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 12, 2024 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Convertible Note Assignment Agreement (March 2022 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Convertible Note Assignment Agreement (August 2021 Promissory Note), by and between Apimeds Pharmaceuticals US, Inc., Apimeds, Inc., and Inscobee Inc., dated June 12, 2024 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
May 2024 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated May 20, 2022 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Amendment to the June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated December 5, 2023 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
June 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Inscobee Inc., dated June 3, 2022 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Amendment to the March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
March 2022 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated March 21, 2022 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Amendment to the August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated December 5, 2023 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
August 2021 Promissory Note by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated August 30, 2021 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Amended Convertible Promissory Note made by CLS Holdings, Inc. in favor of FK Legacy Trust (CLS Holdings USA, Inc., Filed With SEC on September 24, 2024)
Convertible Promissory Note to FK Legacy Trust ($2,600,000) (CLS Holdings USA, Inc., Filed With SEC on September 11, 2024)
Promissory Note dated March 15, 2024 (MYnd Analytics, Inc., Filed With SEC on September 10, 2024)
Form of Promissory Note from SFL Investment Holdings, LLC and Mint Florida Holdings, LLC (Columbia Care Inc., Filed With SEC on August 27, 2024)
Verano Holdings, LLC Promissory Note (Verano Holdings Corp., Filed With SEC on August 22, 2024)
Verano Holdings, LLC Promissory Note (Columbia Care Inc., Filed With SEC on August 22, 2024)
Amended and Restated Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated August 15, 2024 (ProPhase Labs, Inc., Filed With SEC on August 21, 2024)
Promissory note, dated August 16, 2024, issued to Citius Pharmaceuticals, Inc. by Citius Oncology, Inc (Citius Pharmaceuticals, Inc., Filed With SEC on August 16, 2024)
Form of Officers Certificate setting forth the terms and form of the Notes (Lilly (Eli) & Co., Filed With SEC on August 14, 2024)
Form of Senior Secured Convertible Promissory Note to be issued by the Company pursuant to and in accordance with the Securities Purchase Agreement (Big Rock Partners Acquisition Corp., Filed With SEC on August 14, 2024)
Form of Senior Secured Convertible Promissory Note due February 15, 2026 (Angion Biomedica Corp., Filed With SEC on August 12, 2024)
Secured Promissory Note, dated May 2, 2024, by and between Standard Farms LLC and Lender (TILT Holdings Inc., Filed With SEC on August 9, 2024)
Form of Verano Holdings, LLC Promissory Note (Verano Holdings Corp., Filed With SEC on July 31, 2024)
Form of Verano Holdings, LLC Promissory Note (Columbia Care Inc., Filed With SEC on July 31, 2024)
Form of Senior Unsecured Nonconvertible Note (ContraVir Pharmaceuticals, Inc., Filed With SEC on July 22, 2024)
Form of Unsecured Convertible Promissory Note (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on July 17, 2024)
Amendment No. 8 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective July 16, 2024 (APRICUS BIOSCIENCES, INC., Filed With SEC on July 16, 2024)
First Amendment to Promissory Note dated July 3, 2024, by and among Medicine Man Technologies, Inc. a Nevada Corporation, Nuevo Holdco, LLC a New Mexico limited liability company... (Medicine Man Technologies, Inc., Filed With SEC on July 11, 2024)